FDA inspection of Facility verified GMP compliance
Print
Written by Frank Luo
Friday, 31 August 2012 15:35

The FDA GMP re-inspection of our Chongqing ONCOLOGY facility conducted on May 21 – 24, 2012 was most successful, we passed our GMP compliance again ! The first successful FDA GMP compliance approval was in September 2008.

The inspection covered 5 APIs: Docetaxel Anhydrous, Docetaxel Trihydrate, Doxercalciferol, Oxaliplatin, Paclitaxel.

The inspection went smoothly and the EIR was issued on November 19, 2012.

Last Updated on Wednesday, 19 December 2012 17:13